FDA's New Regulatory Paradigm for Stem Cells: How Will This Impact What You Do?

Tue, Dec 5, 2017 4:30 PM - 6:00 PM MST

FDA recently announced a series of guidance documents that may adversely impact several areas of therapy. What do these documents say and mean?

Join experts: attorney Andrew Ittleman and Dr. Chris Centeno on a short presentation and live Q&A session.

To register: